Based on the absolute indications for ESD and our results, we chose variables to predict the risk of lymph node metastasis for our nomogram in patients with EGC and to avoid unnecessary gastrectomy, which included the following: age, tumor size, ulceration, histology, depth of invasion, and HER2 status. The gene discussed is ERBB2; the disease is neoplasm.